GlassScriptPhysician profile
Ashley Gibson
NPI 1700215464
$6,513.73
in general payments reported to CMS, 2019-2025
35 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $1,615 · 2023: $1,832 · 2024: $1,662 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,675.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,153.43 | 2022-2025 | |
| Pfizer INC. | $925.83 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $638.33 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $546.51 | 2022-2025 | Verquvo, Capvaxive, Winrevair |
| Amgen INC. | $539.43 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $489.07 | 2021-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $349.14 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $248.68 | 2022-2024 | Wainua, Brilinta, Farxiga |
| Edwards Lifesciences Corporation | $157.33 | 2024 | |
| Abiomed | $131.63 | 2022-2024 | Impella |
| Lexicon Pharmaceuticals, INC. | $125.06 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $107.22 | 2023-2025 | Wegovy |
| Bridgebio Pharma, INC. | $97.33 | 2025 | Attruby |
| Medicomp INC | $96.90 | 2022 | |
| Becton, Dickinson and Company | $96.85 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $82.77 | 2022-2023 | Kengreal, Cleviprex |
| Boston Scientific Corporation | $68.88 | 2023-2024 | Watchman Flx, Watchman Access System, Bodyguardian |
| Actelion Pharmaceuticals US, INC. | $65.34 | 2023-2025 | Uptravi |
| Philips North America LLC | $63.99 | 2023-2024 | (5044) Mcot |
| Alnylam Pharmaceuticals INC. | $62.00 | 2022-2024 | Onpattro |
| Kestra Medical Technology Services, INC. | $59.93 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $53.48 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $44.88 | 2022-2023 | Evkeeza |
| Inspire Medical Systems, INC. | $42.40 | 2025 | Inspire |
| Daiichi Sankyo INC. | $38.97 | 2023-2024 | Injectafer |
| Medtronic, INC. | $36.40 | 2022 | |
| Inari Medical, INC. | $34.77 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.44 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $22.91 | 2023 | Arcalyst |
| Avanir Pharmaceuticals, INC. | $21.49 | 2021 | |
| Abbott Laboratories | $19.44 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Heartflow, INC. | $18.75 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.86 | 2025 | |
| Alexion Pharmaceuticals, INC. | $14.89 | 2022 | |
| W. L. Gore & Associates, INC. | $14.40 | 2023 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.